Carrier screening and Medicare.

What Medicare covers, who can access it, and where expanded screening sits.

House keys, a phone and a cup of tea on a wooden table by a window

What Medicare funds

Medicare supports reproductive carrier screening for three conditions: cystic fibrosis, spinal muscular atrophy and fragile X syndrome. This is covered under MBS item 73451 for people who are pregnant or planning a pregnancy. The item can generally only be claimed once in a lifetime.

Who is eligible

You need to be eligible for Medicare and either pregnant or planning a pregnancy. You do not need to have a family history of these conditions to access the screening.

How testing works for couples

The pregnant or pregnancy-planning partner is tested first. If they are found to carry cystic fibrosis or spinal muscular atrophy, their reproductive partner can then access Medicare-funded testing for that condition under MBS item 73452.

Fragile X works differently

Fragile X is inherited differently from cystic fibrosis and spinal muscular atrophy, so testing the second partner generally does not provide additional information about the pregnancy risk.

This is why Medicare’s partner-testing pathway applies to cystic fibrosis and spinal muscular atrophy, rather than Fragile X.

What Medicare does not cover

Medicare currently covers screening for these three conditions, but not broader expanded carrier screening panels.

If you choose expanded screening, the additional conditions are tested outside the Medicare rebate.

Without Medicare

If you are not eligible for Medicare, you can still access carrier screening privately. Any applicable testing and consultation costs may apply.

A clearer place to start.

Carrier screening helps you know where you stand and plan for your family with peace of mind.

1. Total Medicare-funded standard carrier screening tests in Australia (items 73451 and 73452), Nov 2023 to Aug 2026. Excludes privately paid screening. Sources: Services Australia MBS item data (data.gov.au); Research Square preprint, 2025.

2. Centre for Genetics Education, NSW Health. Reproductive carrier screening. 2024.

3. Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Genetic Carrier Screening (C-Obs 63). Interim update July 2024.

* May be $0, bulk billed for eligible patients under Medicare item 73451. Medicare covers Standard carrier screening once per lifetime, and eligibility is confirmed before testing proceeds. Without Medicare, a fee applies to the screening and the consultation. Medicare doesn’t cover Expanded screening.


† Our Standard carrier screening results usually take about 3 weeks from when the lab receives your swab. Industry-leading based on our laboratory partner’s turnaround data, October 2026.


‡ Every test includes a telehealth GP consult. A genetic counsellor consult is also included if your results show an increased chance (a higher-risk result).

Elucia screening identifies carrier status. Talk to your healthcare provider about clinical decisions.

1. Total Medicare-funded standard carrier screening tests in Australia (items 73451 and 73452), Nov 2023 to Aug 2026. Excludes privately paid screening. Sources: Services Australia MBS item data (data.gov.au); Research Square preprint, 2025.

2. Centre for Genetics Education, NSW Health. Reproductive carrier screening. 2024.

3. Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Genetic Carrier Screening (C-Obs 63). Interim update July 2024.

* May be $0, bulk billed for eligible patients under Medicare item 73451. Medicare covers Standard carrier screening once per lifetime, and eligibility is confirmed before testing proceeds. Without Medicare, a fee applies to the screening and the consultation. Medicare doesn’t cover Expanded screening.


† Our Standard carrier screening results usually take about 3 weeks from when the lab receives your swab. Industry-leading based on our laboratory partner’s turnaround data, October 2026.


‡ Every test includes a telehealth GP consult. A genetic counsellor consult is also included if your results show an increased chance (a higher-risk result).

Elucia screening identifies carrier status. Talk to your healthcare provider about clinical decisions.

1. Total Medicare-funded standard carrier screening tests in Australia (items 73451 and 73452), Nov 2023 to Aug 2026. Excludes privately paid screening. Sources: Services Australia MBS item data (data.gov.au); Research Square preprint, 2025.

2. Centre for Genetics Education, NSW Health. Reproductive carrier screening. 2024.

3. Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Genetic Carrier Screening (C-Obs 63). Interim update July 2024.

* May be $0, bulk billed for eligible patients under Medicare item 73451. Medicare covers Standard carrier screening once per lifetime, and eligibility is confirmed before testing proceeds. Without Medicare, a fee applies to the screening and the consultation. Medicare doesn’t cover Expanded screening.


† Our Standard carrier screening results usually take about 3 weeks from when the lab receives your swab. Industry-leading based on our laboratory partner’s turnaround data, October 2026.


‡ Every test includes a telehealth GP consult. A genetic counsellor consult is also included if your results show an increased chance (a higher-risk result).

Elucia screening identifies carrier status. Talk to your healthcare provider about clinical decisions.